Celgene to Use Foundation Medicine's Sequencing-Based Test in Cancer Drug Trials

The goal is to use the test to enable targeted recruitment of patient populations and to stratify patients based on their mutational profile to identify those most likely to respond to Celgene's drug candidates.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.